Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Apple Tree Partners
BioCentury | Oct 28, 2024
Emerging Company Profile
Red Queen: A new approach to viral fusion proteins
Apple Tree Partners launches infectious disease company with stapled lipopeptide tech for blocking viral fusion
BioCentury | Aug 9, 2024
Finance
Venture Report: Pair of crossover rounds for precision oncology, peptide biotechs
Plus: Financings for newcos Nilo, Jade, Red Queen
BioCentury | Jun 10, 2024
Deals
Deals Report: Elsie, Seres, Marengo build on existing deals to enter new ones
Plus: A takeout offer for Vanda and an ADC deal for ArriVent and Alphamab
BioCentury | Apr 19, 2024
Management Tracks
Domain, Initial among quartet of biotechs unveiling CEOs
Plus: Jim Jenson becomes CEO of Morphoceuticals, and updates from Xeno, NeoGenomics, DeepUll and Verastem
BioCentury | Feb 9, 2024
Finance
Venture report: Scion’s launch, rounds for Neurona, Attralus and Basking
New firm, affiliated with NYC-based Petrichor, will put $310M fund toward company creation
BioCentury | Dec 15, 2023
Finance
Dec. 14 Quick Takes: Playground Global raises $410M third fund
Plus: ATP launches small molecule discovery company Deep Apple and more from Apellis, Moderna, Merck, Amgen and Huilly
BioCentury | Nov 14, 2023
Management Tracks
Huntsman to head commercial at Madrigal
Plus: Robbins named CEO at Incendia, and updates from Nereid, Affini-T and Geneoscopy
BioCentury | Nov 9, 2023
Regulation
Nov. 8 Quick Takes: FDA approves Lilly’s tirzepatide for weight loss
Plus: Takeda’s fruquintinib approved for colorectal cancer, and updates from Forward, Ascidian, Xencor, UltraDx and more
BioCentury | Aug 1, 2023
Finance
Aug. 1 Quick Takes: Ex-U.S. deal for TG’s Briumvi comes as sales disappoint
Plus: ATP extends Aulos’ series A, Solu debuts with platform from GSK, and more
BioCentury | Jul 12, 2023
Management Tracks
Eisai’s Cheung, head of U.S. and Leqembi lead, retiring
Plus: Paterson becomes CEO of Verastem, and updates from
Items per page:
1 - 10 of 115